SGRY - Surgery Partners, Inc.

QQQ $ 628.93 $ 10.99 (1.78 %)

DIA $ 475.40 $ 3.14 (0.66 %)

SPY $ 685.52 $ 7.99 (1.18 %)

TLT $ 91.88 $ 0.31 (0.34 %)

GLD $ 367.78 $ -10.51 (-2.78 %)

Previous Close

$ 22.9

Open

$ 22.95

Bid

$ 19.05 x 10

Ask

$ 23.25 x 1

Day's Range

$ 22.60 - $ 23.19

52 Week Range

$ 18.87 - $ 31.89

Volume

1,080,513

Average Volume

Market Cap

2.94B

Beta (5Y Monthly)

$ 1.46

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-05-2025	06-30-2025	10-Q
2	05-12-2025	03-31-2025	10-Q
3	03-07-2025	12-31-2024	10-K
4	11-12-2024	09-30-2024	10-Q
5	08-06-2024	06-30-2024	10-Q
6	05-07-2024	03-31-2024	10-Q
7	02-26-2024	12-31-2023	10-K
8	11-07-2023	09-30-2023	10-Q
9	08-01-2023	06-30-2023	10-Q
10	05-02-2023	03-31-2023	10-Q
11	03-01-2023	12-31-2022	10-K
12	11-08-2022	09-30-2022	10-Q
13	08-02-2022	06-30-2022	10-Q
14	05-03-2022	03-31-2022	10-Q
15	03-01-2022	12-31-2021	10-K
16	11-03-2021	09-30-2021	10-Q
17	08-04-2021	06-30-2021	10-Q
18	05-05-2021	03-31-2021	10-Q
19	03-10-2021	12-31-2020	10-K
20	11-04-2020	09-30-2020	10-Q
21	08-05-2020	06-30-2020	10-Q
22	05-11-2020	03-31-2020	10-Q
23	03-13-2020	12-31-2019	10-K
24	11-06-2019	09-30-2019	10-Q
25	08-09-2019	06-30-2019	10-Q
26	05-10-2019	03-31-2019	10-Q
27	03-15-2019	12-31-2018	10-K
28	11-09-2018	09-30-2018	10-Q
29	08-09-2018	06-30-2018	10-Q
30	05-10-2018	03-31-2018	10-Q
31	03-16-2018	12-31-2017	10-K
32	11-09-2017	09-30-2017	10-Q
33	08-09-2017	06-30-2017	10-Q
34	05-10-2017	03-31-2017	10-Q
35	03-10-2017	12-31-2016	10-K
36	11-10-2016	09-30-2016	10-Q
37	08-10-2016	06-30-2016	10-Q
38	05-06-2016	03-31-2016	10-Q
39	03-11-2016	12-31-2015	10-K
40	11-13-2015	09-30-2015	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Cantor Fitzgerald Reiterates Overweight on...
10/07/2025 13:15:01

Cantor Fitzgerald analyst Sarah James reiterates Surgery Partners (NASDAQ:SGRY) with a Overweight and maintains $36 price ta...

JP Morgan Assumes Surgery Partners at Neut...
09/18/2025 11:04:50

JP Morgan analyst Benjamin Rossi assumes Surgery Partners (NASDAQ:SGRY) with a Neutral rating and announces Price Target of ...

On August 4, Surgery Partners Wayne S. De...
08/06/2025 21:38:28

-SEC Filing

Surgery Partners Affirms FY2025 Sales Guid...
08/05/2025 11:32:46

Surgery Partners (NASDAQ:SGRY) affirms FY2025 sales outlook from $3.300 billion-$3.450 billion to $3.300 billion-$3.450 billion...

Surgery Partners Q2 Adj. EPS $0.17 Beats $...
08/05/2025 11:31:31

Surgery Partners (NASDAQ:SGRY) reported quarterly earnings of $0.17 per share which beat the analyst consensus estimate of $0.1...

Earnings Scheduled For August 5, 2025
08/05/2025 08:32:54

surgery-partners-rejects-bain-capitals-private-buyout-offer-will-remain-independent

Surgery Partners Rejects Bain Capital's Pr...
06/17/2025 13:47:36

Surgery Partners rejects Bain Capital's acquisition bid, citing greater long-term value as a public company with strong gro...

Reported Earlier: Surgery Partners Rejects...
06/17/2025 13:22:25

Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facil...

Surgery Partners Reaffirms 2025 Outlook Wi...
06/17/2025 12:13:15

2025 OutlookThe Company reaffirmed its outlook for 2025 revenues and Adjusted EBITDA to be in the range of $3.30 billion to $3....

12 Health Care Stocks Moving In Tuesday's ...
06/17/2025 12:08:52

Assessing Surgery Partners: Insights From ...
05/27/2025 18:00:16

Barclays Maintains Equal-Weight on Surgery...
05/27/2025 16:22:27

Barclays analyst Andrew Mok maintains Surgery Partners (NASDAQ:SGRY) with a Equal-Weight and lowers the price target from $2...

surgery-partners-misses-q1-marks-but-sticks-to-2025-outlook

Surgery Partners Misses Q1 Marks But Stick...
05/12/2025 15:43:12

Surgery Partners reported Q1 revenue of $776 million and earnings of 4 cents per share, reaffirming its 2025 guidance despite m...

Surgery Partners Affirms FY2025 Sales Guid...
05/12/2025 11:33:07

2025 OutlookThe Company reaffirmed its outlook for 2025 revenues and Adjusted EBITDA to be in the range of $3.30 billion to $3....

Surgery Partners Q1 2025 Adj. EPS $0.04 Mi...
05/12/2025 11:31:56

Earnings Scheduled For May 12, 2025
05/12/2025 08:32:31

Benchmark Reiterates Buy on Surgery Partne...
04/21/2025 14:28:30

Benchmark analyst Bill Sutherland reiterates Surgery Partners (NASDAQ:SGRY) with a Buy and maintains $35 price target.

RBC Capital Reiterates Outperform on Surge...
03/25/2025 15:36:56

RBC Capital analyst Ben Hendrix reiterates Surgery Partners (NASDAQ:SGRY) with a Outperform and maintains $35 price target.

Macquarie Maintains Outperform on Surgery ...
03/11/2025 10:55:49

Macquarie analyst Tao Qiu maintains Surgery Partners (NASDAQ:SGRY) with a Outperform and lowers the price target from $34 to...

Surgery Partners Sees FY2025 Revenue $3.30...
03/03/2025 12:37:45

Surgery Partners (NASDAQ:SGRY) sees FY2025 sales of $3.300 billion-$3.450 billion vs $3.38 billion analyst estimate.